Log in to save to my catalogue

Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?

Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4491100

Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?

About this item

Full title

Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Seminars in immunopathology, 2015-07, Vol.37 (4), p.371-376

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Mevalonate kinase deficiency or hyper-IgD syndrome is a hereditary autoinflammatory syndrome caused by mutations in the mevalonate kinase gene. In this review, we will discuss new findings in this disorder that have been published in the last 2 years. This includes new insights into pathophysiology, treatment, and the clinical phenotype linked to t...

Alternative Titles

Full title

Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4491100

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4491100

Other Identifiers

ISSN

1863-2297

E-ISSN

1863-2300

DOI

10.1007/s00281-015-0492-6

How to access this item